Metrifonate: A Review of its Use in Alzheimer’s Disease

Author： Ormrod D.   Spencer C.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.13, Iss.6, 2000-06, pp. : 443-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer’s Disease

By Lamb H.M.   Goa K.L.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 303-318

Adis International

Access to resources Recommend Favorite

Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer’s disease

By Cummings J.L.   Ringman J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 463-471

Informa Healthcare

Access to resources Recommend Favorite

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A.   Grossberg G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M.   Noble S.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite

Galantamine: A Review of its Use in Alzheimer's Disease

By Scott L.J.   Goa K.L.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1095-1122

Adis International

Access to resources Recommend Favorite